---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-25-001046"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2025-06-13T23:59:59+00:00"
generated_at: "2026-05-19T08:26:22.125173+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences completes 1-for-6 reverse stock split; Nasdaq compliance regained

## Summary
- Effective 12:01 a.m. ET June 13, 2025; each 6 pre-split shares combine into 1 post-split share; outstanding shares reduced from 3,280,000 to ~546,667.
- Authorized common shares reduced from 50M to 8,333,333; preferred authorized reduced from 416,667 to 69,444.
- New CUSIP: 04301G607. No fractional shares; holders receive one whole share for any fractional entitlement.
- Warrants adjust: each 6 pre-split warrants (exercise $0.75) combine into 1 warrant exercisable at $4.50 per post-split share.
- Nasdaq confirmed on June 13, 2025 that ARTL regained compliance with the $1.00 minimum bid price requirement; deficiency matter closed.

## SEC filing metadata
- accession: 0001640334-25-001046
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2025-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 3.03, 5.03, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/0001640334-25-001046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-25-001046
- JSON: https://secwatch.observer/filing/0001640334-25-001046.json
- Plain text: https://secwatch.observer/filing/0001640334-25-001046.txt

## Key facts
- Governance Changes
  ARTELO BIOSCIENCES, INC.: Effected a one-for-six reverse stock split of common stock and proportionally reduced authorized shares (effective 2025-06-13).
  - Change: charter amendment
  - Effective: 2025-06-13
  source text: On June 12, 2025, Artelo Biosciences, Inc., a Nevada corporation (the “Company”), filed with the Secretary of State of the State of Nevada a Certificate of Change (the “Certificate of Change”), pursuant to Nevada Revised Statutes 78.209, to effect a one-for-six (1-for-6) reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock, par value $0.001 per share (the “Common Stock”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1621221/000164033425001046/0001640334-25-001046-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.